| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1513 | |
| Phytochemical name or plant extracts | Julibroside J19 | |
| PMID | 16308192 | |
| Literature evidence | Both compounds show significant inhibition action against HeLa, Bel-7402 and MDA-MB-435 cancer cell lines in vitro. | |
| IUPAC name | 3-O-[beta-D-xylopyranosyl-(1 --> 2)-beta-D-fucopyranosyl-(1 --> 6)-beta-D-2-deoxy-2-acetoamidoglucopyranosyl]-21-O-{(6S)-2-trans-2-hydroxymethyl-6-methyl-6-O-[4-O-((6S)-2-trans-2-hydroxymethyl-6-hydroxy-6-methyl-2,7-octadienoyl)-beta-D-quinovopyranosyl]-2,7-octadienoyl}-acacic acid-28-O-beta-D-glucopyranosyl-(1 --> 3)-[alpha-L-arabinofuranosyl-(1 --> 4)]-alpha-L-rhamnopyranosyl-(1 --> 2)-beta-D-glucopyranosyl ester | |
| Phytochemicals’ class or type of plant extracts | Saponin | |
| Source of phytochemicals or plant Extracts | Albizzia julibrissin Durazz | |
| Geographical availability | Assam, Bangladesh, China North-Central, China South-Central, China Southeast, East Himalaya, India, Iran, Japan, Korea, Myanmar, Nansei-shoto, Nepal, Pakistan, Taiwan, Tibet, Transcaucasus, West Himalaya | |
| Plant parts | Stem | |
| Other cancers | Breast cancer, Cervical cancer, Liver cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | Both 1 and 2 show significant cytotoxicities against the cancer cell lines at 100 mg ml21 assayed by SRB method. Compound 1 is Julibroside J19 | |
| Cell line/ mice model | HeLa, Bel-7402 and MDA-MB-435 | |
| Additional information | Shows significant cytotoxicity against HeLa, Bel-7402 and MDA-MB-435 cell lines | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:473275-1 | |
| Safety | NA |